XLV, the Health Care Select Sector SPDR ETF, closes the week with a curious split: short sellers are pulling back, yet options traders are running the most defensive book they have in months.
The options signal is the standout this week. Put demand is running well above its recent norm — the put/call ratio hit 1.41 on Tuesday, its highest reading in the past several weeks and about 1.4 standard deviations above the 20-day average of 1.35. That's not panic territory by any stretch; the 52-week high PCR is 2.67, so there's room to go much further. But the direction of travel is clear: every session since early August has logged a higher PCR than the July average, and the drift has been consistent. Investors are buying more downside protection on healthcare even as the ETF itself grinds higher.
Short positioning tells the opposite story, and that contrast is worth naming explicitly. SI has fallen roughly 12% on the week — continuing the sharp covering trend flagged in the prior note — and now sits at 5.2% of free float, down from a recent peak above 6%. The ORTEX short score has also retreated, easing to 47.8 from 51.8 a week ago. Borrow conditions are loose, with cost to borrow at 0.42% and availability at 258% — meaning roughly 2.5 shares are available in the lending pool for every one currently borrowed. The 52-week minimum availability was 24%, so the lending market is relaxed by any historical comparison. This is not a crowded short; it looks like the tactical positioning that spiked in late July has now largely been unwound.
The price action backs the short-covering read. XLV added 1.0% on the week and is up 5.4% over the past month, closing at $169.73. The broader institutional picture is mixed at the margin — JPMorgan trimmed its position by roughly 2.7 million shares in the most recent quarter-end filing, while Envestnet cut by nearly 1 million. In contrast, Managed Account Advisors added 2.9 million shares and UBS Asset Management built by 435,000. Net, the holder base of 442 institutions is broadly stable, with no dominant directional signal from the ownership side.
The tension heading into next week is straightforward: put buyers are hedging a rally, short sellers are stepping aside, and the ETF keeps ticking higher. Whether the options caution reflects genuine sector-level concern — policy risk around healthcare reform or pricing pressure on large-cap pharma — or simply routine portfolio hedging from the ETF's naturally put-heavy investor base is the question worth watching as August draws to a close.
See the live data behind this article on ORTEX.
Open XLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
